TGFB1 and graft versus host disease: In a recent study [193] MSC-derived exosomes (Figure 2), harbouring large amount of HLA-G, IL-10 and TGFβ, were used to treat a patient suffering from severe and therapy-refractory cutaneous and intestinal GvHD grade IV.